Suppr超能文献

源自乙肝病毒X蛋白Kunitz结构域的保守肽通过蛋白酶体途径对HepG2细胞周期和凋亡的影响

Effect of a conserved peptide derived from Kunitz domain of hepatitis B virus x protein on the cell cycle and apoptosis of HepG2 cells via the proteasome pathway.

作者信息

Liu Hong, Ye Lin, Wang Qing-wei, Yan Qiu-xia, Yu Jin-ming

机构信息

Cancer Research Center, Qilu Hospital, Shandong University, Medical School of Shandong University, Jinan, Shandong 250012, China.

出版信息

Chin Med J (Engl). 2009 Feb 20;122(4):460-5.

Abstract

BACKGROUND

Hepatitis B virus (HBV) x protein (HBx) in HepG2 cells causes a moderate decrease in proteolysis activity of the proteasome. A highly conserved Kunitz-type serine protease inhibitor domain within 154 amino acid residues of HBx has been identified. In this study, a peptide chain derived from the Kunitz domain (PKD) was used to study its effect on the cell cycle and apoptosis of HepG2 cells, and investigated the function of PKD on the activities of proteasomes and AAA-ATPase p97, which involves in the ubiquitin-proteasome protein degradation pathway.

METHODS

The PKD peptide (Phe-Val-Leu-Gly-Gly-Cys-Arg-His-Lys) was chemically synthesized. MTT assays were used to determine the effects of PKD on HepG2 cell growth. Mouse anti-p97 antibody was developed for Western blotting to detect the expression of p97. ATPase activity of proteasomes was measured using a colorimetric assay. Peptidase activities of proteasomes were analyzed with various peptidase-specific fluorogenic peptide substrates. Flow cytometry was used to determinate cell cycle phase and apoptosis.

RESULTS

Viability of HepG2 cells decreased in a PKD-dose-dependent manner. Cells exhibited significant cytotoxicity in the presence of 15 mmol/L of PKD. Western blotting analysis showed that expression of p97 was suppressed in HepG2 cells treated with PKD compared to untreated cells. The ATPase activity of proteasomes from immunoprecipitates of HepG2 cells pretreated with PKD was apparently decreased. Chymotryptic activity of proteasomes in HepG2 cells was significantly inhibited by 10 mmol/L PKD; tryptic activity and peptidylglutamyl peptide hydrolase activity of proteasomes were less inhibited by PKD than chymotryptic activity. The cell cycle phase of HepG2 cells treated with PKD for 36 hours was blocked largely at the G(0)-G(1) phase, while untreated control cells were mainly in S phase. PKD also significantly induced apoptosis.

CONCLUSIONS

The peptide derived from Kunitz domain of HBx protein induces HepG2 cell growth arrest and apoptosis, which may result from down-regulation of p97 expression, and decrease of both the ATPase and chymotryptic activities of proteasomes.

摘要

背景

乙型肝炎病毒(HBV)X蛋白(HBx)在HepG2细胞中会导致蛋白酶体的蛋白水解活性适度降低。已在HBx的154个氨基酸残基内鉴定出一个高度保守的Kunitz型丝氨酸蛋白酶抑制剂结构域。在本研究中,使用源自Kunitz结构域的肽链(PKD)来研究其对HepG2细胞周期和凋亡的影响,并研究PKD对蛋白酶体和AAA-ATP酶p97活性的作用,p97参与泛素-蛋白酶体蛋白降解途径。

方法

化学合成PKD肽(苯丙氨酸-缬氨酸-亮氨酸-甘氨酸-甘氨酸-半胱氨酸-精氨酸-组氨酸-赖氨酸)。采用MTT法测定PKD对HepG2细胞生长的影响。制备小鼠抗p97抗体用于蛋白质印迹法检测p97的表达。使用比色法测定蛋白酶体的ATP酶活性。用各种肽酶特异性荧光肽底物分析蛋白酶体的肽酶活性。采用流式细胞术测定细胞周期阶段和凋亡情况。

结果

HepG2细胞的活力以PKD剂量依赖性方式降低。在存在15 mmol/L PKD的情况下,细胞表现出明显的细胞毒性。蛋白质印迹分析表明,与未处理的细胞相比,用PKD处理的HepG2细胞中p97的表达受到抑制。用PKD预处理的HepG2细胞免疫沉淀物中蛋白酶体的ATP酶活性明显降低。10 mmol/L PKD显著抑制HepG2细胞中蛋白酶体的胰凝乳蛋白酶活性;PKD对蛋白酶体的胰蛋白酶活性和肽基谷氨酰肽水解酶活性的抑制作用小于对胰凝乳蛋白酶活性的抑制作用。用PKD处理36小时的HepG2细胞的细胞周期阶段主要阻滞在G(0)-G(1)期,而未处理的对照细胞主要处于S期。PKD也显著诱导凋亡。

结论

源自HBx蛋白Kunitz结构域的肽诱导HepG2细胞生长停滞和凋亡,这可能是由于p97表达下调以及蛋白酶体的ATP酶和胰凝乳蛋白酶活性降低所致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验